A. Marcelin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A large clinical care and research organization in Haiti required an electronic medical record system (EMR) to serve the needs of its 30 interlinked clinical programs. After assessing available open source software, the local team designed and implemented a modular proprietary EMR that is improving data quality and patient care. Despite the many benefits of(More)
Purpose of the study Fos-Amprenavir is one of the protease inhibitor that is recommended to treat protease inhibitor naïve of experienced patients. Amprenavir and darunavir share at least in part chemical structures and thus a possible selection of close protease gene mutations. Little is known about the frequency and the type of resistance mutations(More)
Purpose of the study Darunavir is one of the protease inhibitors that is recommended to treat protease inhibitor-naïve or-experienced patients. Recent studies have determined the spectrum of darunavir activity in patients failing to antiretroviral therapy. Darunavir resistance mutations in protease gene have been identified and allow to classify viruses as(More)
  • 1